Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 4
Subtitle 34 - BOARD OF PHARMACY
Chapter 10.34.35 - Infusion Pharmacy Services in an Alternate Site Care Environment
Section 10.34.35.04 - Pharmacist Responsibilities
Universal Citation: MD Code Reg 10.34.35.04
Current through Register Vol. 51, No. 19, September 20, 2024
A. A pharmacist in an infusion pharmacy shall adhere to the policies and procedures set forth in Regulation .06 of this chapter.
B. A pharmacist shall:
(1) Provide infusion therapy services in
accordance with:
(a) Orders issued by a
licensed authorized prescriber of record; and
(b) Where applicable, protocols issued by a
licensed authorized prescriber of record.
(2) Perform and document initial and ongoing
assessments of the appropriateness of infusion therapy using the following
information:
(a) Patient demographics
including:
(i) Name;
(ii) Address;
(iii) Telephone number;
(iv) Gender; and
(v) Date of birth;
(b) Emergency contact information;
(c) Diagnoses, including:
(i) Diagnosis being treated; and
(ii) Concurrent conditions, including
pregnancy and lactation status if applicable;
(d) Medical history;
(e) Allergies;
(f) If applicable, height;
(g) Weight;
(h) Parenteral medication orders, including
length of therapy;
(i) Parenteral
infusion access device:
(i)
Location;
(ii) Type; and
(iii) If available, date of
placement;
(j) Ongoing
medication profile review and reconciliation at end of therapy;
(k) First dose status;
(l) Caregiver information including, but not
limited to:
(i) Name;
(ii) Address;
(iii) Phone number; and
(iv) Relationship to patient;
(m) If applicable, contact
information for other agencies or individuals involved in the patient's home
care;
(n) Documented applicable
medical and social factors and functional limitations which may affect infusion
therapy including but not limited to:
(i)
Language;
(ii) Sight;
(iii) Hearing;
(iv) History of IV drug abuse;
(v) History of drug or alcohol abuse;
or
(vi) Other physical or mental
limitations; and
(o) If
applicable to therapy, baseline labs;
(3) Create a patient care plan specific to
the patient's:
(a) Diagnosis;
(b) Prescribed therapy; and
(c) Concurrent conditions;
(4) When compounding sterile
preparations, comply with COMAR 10.34.19;
(5) If sterile compounding is outsourced,
comply with COMAR 10.34.04;
(6) As
applicable, retrieve and assess lab values and other monitoring
parameters;
(7) Document in the
patient chart:
(a) New prescription
orders;
(b) Changes in prescription
orders;
(c) Information obtained
from the patient or caregiver; and
(d) Other necessary information obtained from
the:
(i) Patient;
(ii) Caregiver;
(iii) Infusion nurse;
(iv) Licensed authorized prescriber of
record; or
(v) Other sources
relevant to patient care;
(8) Verify prescription label
accuracy;
(9) Communicate as
appropriate, throughout the patient's therapy with the:
(a) Licensed authorized prescriber of record
or agent of the licensed authorized prescriber of record;
(b) Patient's infusion nurse;
(c) Patient; and
(d) Caregiver; and
(10) Review therapy-specific considerations
such as pain and nutrition status.
Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.